Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter KRT17 Antikörper

Der Kaninchen Monoklonal anti-KRT17 Antikörper wird verwendet zum Nachweis von KRT17 in Proben von Human. Er wurde validiert für IHC.
Produktnummer ABIN7864319
687,58 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für Rekombinanter KRT17 Antikörper (ABIN7864319)

Target

Alle KRT17 Antikörper anzeigen
KRT17 (Keratin 17 (KRT17))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 168
  • 62
  • 42
  • 20
  • 15
  • 13
  • 6
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 133
  • 44
  • 1
Kaninchen

Klonalität

  • 97
  • 80
  • 1
Monoklonal

Konjugat

  • 89
  • 16
  • 8
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser KRT17 Antikörper ist unkonjugiert

Applikation

  • 127
  • 76
  • 43
  • 37
  • 35
  • 33
  • 27
  • 26
  • 25
  • 16
  • 15
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Klon

KRT17-8346R
  • Verwendungszweck

    Recombinant Cytokeratin 17 (CK17) (Basal Epithelial Marker) Antibody

    Spezifität

    CK17 is normally expressed in the basal cells of complex epithelia but not in stratified or simple epithelia. Antibody to CK17 is an excellent tool to distinguish myoepithelial cells from luminal epithelium of various glands 79oΩsuch as mammary, sweat and salivary. CK17 is expressed in epithelial cells of various origins, such as bronchial epithelial cells and skin appendages. It may be considered as epithelial stem cell marker because CK17 Ab marks basal cell differentiation. CK17 is expressed in SCLC much higher than in LADC. Eighty-five percent of the triple negative breast carcinomas immunoreact with basal cytokeratins including anti-CK17. Also important is that cases of triple negative breast carcinoma with expression of CK17 show an aggressive clinical course. Additionally, anti-CK17 and anti-MUC1 immunoreactivity represents pancreatobiliary subtype whereas anti-MUC2 and anti-CDX-2 positivity defines intestinal subtype.

    Aufreinigung

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment of human KRT17 protein (exact sequence is proprietary)

    Isotyp

    IgG, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Target

    KRT17 (Keratin 17 (KRT17))

    Andere Bezeichnung

    Cytokeratin 17

    Hintergrund

    K17, Keratin Type I Cytoskeletal 17, Keratin-17, KRT17, PCHC1

    bladder or cervix.|T24 cells. Human skin

    Molekulargewicht

    46kDa

    Gen-ID

    3872, 2785

    UniProt

    Q04695
Sie sind hier:
Chat with us!